ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
119.48
+1.29 (1.09%)
Aug 21, 2026, 10:05 AM EDT - Market open
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 80 employees as of March 31, 2026. The number of employees increased by 11 or 15.94% since the number was last reported on December 31, 2025.
Employees
80
Change
11
Growth
15.94%
Revenue / Employee
$70,910
Profits / Employee
-$4,787,847
Market Cap
10.95B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 80 | 11 | 15.94% | 80 | 0 |
| Dec 31, 2025 | 69 | 0 | - | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| Ionis Pharmaceuticals | 1,480 |
| Axsome Therapeutics | 1,346 |
| Cytokinetics | 673 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
| Summit Therapeutics | 265 |
| Apogee Therapeutics | 261 |
ABVX News
- 20 days ago - AbbVie Q2 Earnings Call Highlights - Nasdaq
- 21 days ago - Abivax (ABVX) Advances Toward NDA Filing Amid Mixed Market Signals - GuruFocus
- 21 days ago - Abivax announces positive pre-NDA interaction with FDA for obefazimod in UC - TheFly
- 4 weeks ago - Abivax price target raised to $180 from $132 at Morgan Stanley - TheFly
- 5 weeks ago - Abivax Secures Funding to Advance Ulcerative Colitis Drug (ABVX) - GuruFocus
- 6 weeks ago - Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC - CNBC
- 6 weeks ago - Best defense is the offence, says Abivax CEO after takeover speculation - CNBC
- 6 weeks ago - ABIVAX Société Anonyme Slides: Corporate presentation - Filings